Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 5.

Journal Article

Heilmann-Heimbach, S., Herold, C., Hochfeld, L. M., Hillmer, A. M., Nyholt, D. R., Hecker, J., Javed, A., Chew, E. G. Y., Pechlivanis, S., Drichel, D., Heng, X., del Rosario, R. C. H., Fier, H. L., Paus, R., Ruedi, R., Galesloot, T. E., Moebus, S., Anhalt, T., Prabhakar, S., Li, R., Kanoni, S., Papanikolaou, G., Papanikolaou, G., Kutalik, Z., Deloukas, P., Philpott, M. P., Waeber, G., Spector, T. D., Vollenweider, P., Kiemeney, L. A. L. M., Dedoussis, G., Richards, J. B., Nothnagel, M. ORCID: 0000-0001-8305-7114, Martin, N. G., Becker, T., Hinds, D. A. and Noethen, M. M. (2018). GWAS meta-analysis yields novel insights into the biology of male-pattern baldness. Eur. J. Hum. Genet., 26. S. 761 - 763. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5438

Janning, M., Sueptitz, J., Albers-Leischner, C., Delpy, P., Tufman, A., Velthaus-Rusik, J-L, Reck, M., Jung, A., Kauffmann-Guerrero, D., Bonzheim, I, Braendlein, S., Hummel, H-D, Wiesweg, M., Schildhaus, H-U, Stratmann, J. A., Sebastian, M., Alt, J., Buth, J., Esposito, I, Berger, J., Toegel, L., Saalfeld, F. C., Wermke, M., Merkelbach-Bruse, S., Hillmer, A. M., Klauschen, F., Bokemeyer, C., Buettner, R., Wolf, J. and Loges, S. (2022). Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNuM). Ann. Oncol., 33 (6). S. 602 - 616. AMSTERDAM: ELSEVIER. ISSN 1569-8041

Marquez, Ma Garcia, Thelen, M., Bauer, E., Wennhold, K., Lehmann, J., Keller, D., Maas, L., Nicolik, M., George, J., Zander, T., Schroeder, W., Mueller, P., Bruns, C., Thomas, R., Gathof, B., Quaas, A., Hillmer, A. M., Peifer, M., von Bergwelt-Baildon, M. and Schloesser, H. A. (2022). HEREDITARY HOMOZYGOSITY AND ALLELIC IMBALANCE OF HLA AS COMMON IMMUNE ESCAPE MECHANISMS IN ESOPHAGEAL ADENOCARCINOMA. J. Immunother. Cancer, 10. S. A38 - 1. LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426

Nogova, L., Malchers, F., Hillmer, A. M., Merkelbach-Bruse, S., Pinto, A., Scheel, A. H., Siemanowski, J., Ueckeroth, F., Scheffler, M., Hummel, H. -D., Kern, J., Wermke, M., Kolbe, M., Grohe, C., Stratmann, J., Sebastian, M., Trummer, A., Weber, J. -P., Westphal, T., Michels, S., Koleczko, S., Sueptitz, J., Keser, E., Kron, A., Riedel, R., Abdulla, D. S. Y., Zadoyan, G., Sweiti, H., Santiago-Walker, A., Rothe, A., Draube, A., Sandler, A., Rodermann, E., Linck, D., Thomas, R. K., Buettner, R. and Wolf, J. (2020). FIND: a phase II study to evaluate the efficacy of erdafitinib in FGFR-altered NSCLC. Oncol. Res. Treat., 43 (SUPPL 4). S. 146 - 148. BASEL: KARGER. ISSN 2296-5262

Thelen, M., Keller, D., Lehmann, J., Wennhold, K., Weitz, H., Bauer, E., Gathof, B., Brueggemann, M., Kotrova, M., Quaas, A., Mallmann, C., Chon, S., Hillmer, A. M., Bruns, C., von Bergwelt-Baildon, M., Garcia-Marquez, M. A. and Schloesser, H. A. (2022). IMMUNE RESPONSES AGAINST SHARED ANTIGENS ARE COMMON IN ESOPHAGO-GASTRIC CANCER AND CAN BE ENHANCED USING CD40-ACTIVATED B CELLS. J. Immunother. Cancer, 10. S. A24 - 1. LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426

This list was generated on Fri Mar 29 12:50:41 2024 CET.